Stock listing

KAPA Stock Price, News, Filings & Events — Kairos Pharma, Ltd.

Selected listing: KAPA · AMEX · USD · US

This page tracks Kairos Pharma, Ltd.'s KAPA:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KAPA:AMEX. KAPA:AMEX is the stock-level entry point for investors researching Kairos Pharma, Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kairos Pharma, Ltd. (Ticker: KAPA) is a public company based in America with a market capitalization of approximately $6.1 million. The company is focused on developing innovative pharmaceutical solutions. Investors can find detailed information about its operations and market presence on its public company page.

KAPA:AMEXUSDUSUpdated September 12, 2026
Kairos Pharma, Ltd. logo
Ticker
KAPA:AMEX
Asset type
Stock
Market cap
$6.0M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
AMEX
Currency
USD

Kairos Pharma, Ltd. KAPA:AMEX stock context

This page tracks Kairos Pharma, Ltd.'s KAPA:AMEX listing on AMEX in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following KAPA:AMEX. KAPA:AMEX is the stock-level entry point for investors researching Kairos Pharma, Ltd., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Kairos Pharma, Ltd. (Ticker: KAPA) is a public company based in America with a market capitalization of approximately $6.1 million. The company is focused on developing innovative pharmaceutical solutions. Investors can find detailed information about its operations and market presence on its public company page.

Latest news from Kairos Pharma, Ltd.

All Kairos Pharma, Ltd. news →

Research Kairos Pharma, Ltd.

Alternate listings